Systematic review of longitudinal studies on chemotherapy‐associated subjective cognitive impairment in cancer patients
Authors:
- 3 February 2020
- journal article
- review article
- Published by Wiley in Psycho-Oncology
- Vol. 29 (4) , 617-631
Abstract
Objectives: This systematic review of longitudinal studies, assessing subjective cognitive impairment (SCI) reported by adult cancer patients, aimed to summarize evidence on the impact of chemotherapy on SCI, identify moderators of SCI, and evaluate methodological issues.Methods: Data accrued from Pubmed, EMBASE, CINAHL, PsychInfo, and the Cochrane library. Inclusion criteria were original studies, an exclusively adult sample, valid and reliable subjective cognitive measures, and at least one baseline data point prior to and another after the initiation of chemotherapy. Data were collected on the sample composition, data‐collection time points, outcome measures, statistical analysis, and major findings (ie, longitudinal changes in prevalence, severity, and associated factors).Results: Forty articles published between 2004 and 2019 were retained: 21 examined chemotherapy‐treated patients only, and 19 employed control groups. Findings were mixed, with slightly more studies supporting the impact of chemotherapy on SCI. SCI tended to be more prevalent and severe after initiating chemotherapy, compared with patients' own baseline and controls not treated with chemotherapy. Impact appeared to be acute and more likely limited to subsamples. Most studies examining non–breast‐cancer samples reported the lack or limited impact of chemotherapy on SCI. The most consistent moderators were depression and fatigue. Methodological issues regarding sampling design, measurement, and statistical analysis were discussed.Conclusion: More rigorously designed longitudinal studies would clarify direct and indirect effects of chemotherapy on SCI.Keywords
Funding Information
- Ministry of Education, Science and Technology (2016R1A2B4009800)
This publication has 73 references indexed in Scilit:
- Longitudinal assessment of chemotherapy-induced changes in brain and cognitive functioning: A systematic reviewNeuroscience & Biobehavioral Reviews, 2018
- New Challenges in Psycho‐Oncology Research IV: Cognition and cancer: Conceptual and methodological issues and future directionsPsycho-Oncology, 2018
- Impact of Cancer and Its Treatments on Cognitive Function: Advances in Research From the Paris International Cognition and Cancer Task Force Symposium and Update Since 2012Journal of Pain and Symptom Management, 2015
- A Meta-Analysis of Cognitive Impairment and Decline Associated with Adjuvant Chemotherapy in Women with Breast CancerFrontiers in Oncology, 2015
- Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer‐related cognitive impairment in adultsCA: A Cancer Journal for Clinicians, 2014
- A meta-analysis of cognitive impairment following adult cancer chemotherapy.Neuropsychology, 2014
- Meta-Analysis of Cognitive Functioning in Breast Cancer Survivors Previously Treated With Standard-Dose ChemotherapyJournal of Clinical Oncology, 2012
- Subjective cognitive dysfunction in breast cancer patients: a systematic reviewPsycho-Oncology, 2010
- The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: A meta-analysis of the current literatureBrain and Cognition, 2005
- Neuropsychological effects of treatments for adults with cancer: A meta-analysis and review of the literatureJournal of the International Neuropsychological Society, 2003